Patent
US 11,079,371CHEMICAL SENSORS WITH NON-COVALENT SURFACE MODIFICATION OF GRAPHENE
Xue Zhen
US
Copyright © 2026 Matter42. All rights reserved.
Patent
Atlas literature
Patent
US 11,079,371Patent drawings and their descriptions. Click a drawing to enlarge it.
FIG. 1. A gate electrode can be formed by etching a depression into the insulator layer and then depositing an electrically conductive material in the …
FIG. 2. Graphene varactor 100 includes eight gate electrode fingers 106a-106h. It will be appreciated that while graphene varactor 100 shows eight gate …
FIG. 3, a schematic top plan view of a chemical sensor element 300 is shown in accordance with various embodiments herein. The chemical sensor element 300 can …
FIG. 4, a schematic diagram of a portion of a measurement zone 400 is shown in accordance with various embodiments herein. A plurality of discrete graphene …
FIG. 5, a schematic diagram of a passive sensor circuit 502 and a portion of a reading circuit 522 is shown in accordance with various aspects herein. In some …
FIG. 6, a schematic view of a system 600 for sensing gaseous analytes in accordance with various embodiments herein is shown. The system 600 can include a …
FIG. 7, a schematic view of a system 700 for sensing gaseous analytes in accordance with various embodiments herein is shown. In this embodiment, the system is …
FIG. 8, a schematic cross-sectional view is shown of a portion of a chemical sensor element 800 in accordance with various embodiments herein. The chemical …
FIG. 9. The relative surface coverage for the adsorption of Pyr-CH₂OH to graphene as a function of the logarithm of the concentration of Pyr-CH 2 OH in the …
FIG. 10. In the above example, the Langmuir model is used to determine K from contact angle data. Instead of contact angle data, the intensity of bands in …
FIG. 11) reveals five types of carbon atoms, which can be assigned to C = C (284.5 eV), C-OH (285.4 eV), C- O -C (286.4 eV), C= O (287.4 eV) and O-C= 0 (288.9 …
FIG. 12 is a representative high-resolution XPS spectrum and fits in accordance with various embodiments herein.
FIG. 13 is a representative high-resolution XPS spectrum and fits in accordance with various embodiments herein.
FIG. 14 is a representative high-resolution XPS spectrum and fits in accordance with various embodiments herein.
FIG. 15. The data show the relative monolayer coverage (dots) along with a fit (solid line) based on Langmuir adsorption theory for the adsorption of graphene …
FIG. 16. Aspects may be better understood with reference to the following examples. These examples are intended to be representative of specific embodiments, …
FIG. 17. Example 5: Synthesis of Pyr-CH 2 N(CH 2 CH 3) 2 SVG 16280635.02-20-2019.JSDP₅₇E₅RXEAPX5.SPEC.35.3.950.584.1600.894.svg 1.033 2.167 Chemistry Black and …
FIG. 18. Example 6: Synthesis of Perbenzylated a -, 3 -, and 7 -cyclodextrins SVG 16280635.02-20-2019.JSDP₅₇E₅RXEAPX5.SPEC.36.3.996.676.1554.966.svg 0.967 1.86 …
FIG. 19. The yellow liquid raw product was washed with hexane to remove most of the remaining benzyl chloride, followed by purification chromatography on …
FIG. 20. The logarithm of the concentration as a function of relative surface coverage for the adsorption of pyrene to graphene is shown in
FIG. 21. Individual data points (dots) and a fit (solid line) based on Langmuir adsorption theory for Pyr-CH 2 OH is shown in
FIG. 22. The relative surface coverage for the adsorption of Pyr-CH 2 COO CH 3 to graphene as a function of the logarithm of the concentration of Pyr-CH 2 COO …
FIG. 23. Individual data points (dots) and a fit (solid line) based on Langmuir adsorption theory for Pyr-CH 2 NH 2 HCl is shown in
FIG. 24. The relative surface coverage for the adsorption of Pyr-CH 2 NH 2 -HCl to graphene as a function of the logarithm of the concentration of Pyr-CH 2 NH …
FIG. 25. Individual data points (dots) and a fit (solid line) based on Langmuir adsorption theory for Pyr-CH 2 NH 2 is shown in
FIG. 26. The relative surface coverage for the adsorption of Pyr-CH₂NH₂ to graphene as a function of the logarithm of the concentration of Pyr- CH 2 NH 2 in …
FIG. 27.Table 2. Contact angle of DI water on bare graphene and graphene modified with Pyr- CH₂NH 2-HCl, Pyr-CH₂NH2, or Pyr-CH₂ COO CH 3. SVG …
FIG. 28. The peak height ratios for the B-OH peak (1283 SVG 16280635.02-20-2019.JSDP₅₇E₅RXEAPX5.SPEC.48.11.1512.1190.1623.1243.svg 0.177 0.37 Chemistry Black …
Claims define the patent's legal scope. Independent claims stand alone; dependent claims (nested) narrow them. Click a claim to expand its dependents.
A medical device comprising: a graphene varactor comprising: a graphene layer; a self-assembled monolayer disposed on an outer surface of the graphene layer through 7L-7L stacking interactions; and wherein the self-assembled monolayer provides a Langmuir theta value of at least 0.9i wherein the self-assembled monolayer comprises at least one metallotetraphen y lporph y rin compound having the formula SVG 16280635.03-17-2021.KMDW₆CN₆LDFLYX7.CLM.1.svg 2.95 3.86 Black and white wherein M is any metal atom comprising aluminum, calcium, magnesium, manganese, iron, cobalt, nickel, zin c, ruthenium, palladium, or derivatives thereof, where n can be any integer from 1 to 5; m can be 1 or 2; R' through R 8 comprise -H, -X, where X is any halogen atom; -R 9; -R 1 0 0H -R"COOH -R₁ 2 COOR 3; -R₁ 4 0R 15, -R₁ 6 COH-SVG 16280635.03-17-2021.KMDW₆CN₆LDFLYX7.CLM.2.svg 0.17 5.93 Black and white is any halogen atom, -R 28 SH or any combination thereof, and R 9, through R 28 comprise any linear or branched C 1-C₁₂ alkyl, C 1-C₁₂ alken y l, C 1-C₁₂ alk yny l, or any combination thereof, or can be absent such that the remaining portion of the functional group is covalently bound directly to one or more carbon atoms of the base aromatic ring structure. Currently amended
The medical device of claim 1, the self-assembled monolayer comprising one or more hydrocarbons comprising 3 to 10 aromatic rings. Withdrawn
The medical device of claim 1, the self-assembled monolayer comprising one or more polycyclic aromatic hydrocarbons comprising 3 to 10 aromatic rings. Withdrawn
The medical device of claim 1, the self-assembled monolayer comprising: SVG 16280635.03-17-2021.KMDW₆CN₆LDFLYX7.CLM.3.svg 1.28 2.89 Black and white wherein X 1, X 2, X 3, and X 4 comprise any linear, branched, or cyclic C 1-Ci o alkyl covalently bound directly to the base aromatic ring structure, -H, -R ' OH, -R 2 COO H,-SVG 16280635.03-17-2021.KMDW₆CN₆LDFLYX7.CLM.4.svg 0.18 5.87 Black and white thereof, and R 1 through R 1 2 comprise any linear, branched, or cyclic C 1-Ci o alkyl, or a combination thereof, or can be absent such that the remaining portion of the functional group is covalently bound directly to one or more carbon atoms of the base aromatic ring structure. Withdrawn
The medical device of claim 1, the self-assembled monolayer comprising: SVG 16280635.03-17-2021.KMDW₆CN₆LDFLYX7.CLM.5.svg 0.94 1.85 Black and white where n is an integer from 6 to 8, and each X can independently be -H, hydroxyl, amino, any linear or branched C 1 -C l o alcohol, any linear or branched C i -Cio amines, phenyl, benzyl, or naphthyl groups, provided that each repeating unit in the structure above includes at least one X that is an aromatic functional group. Withdrawn
The medical device of claim 1, the self-assembled monolayer comprising: SVG 16280635.03-17-2021.KMDW₆CN₆LDFLYX7.CLM.6.svg 2.83 4.02 Black and white wherein n is any integer from 1 to 5; m is 1 or 2; R 1 through R 8 comprise -H; -X, where X comprises a halogen atom; -R 9; -R 1 0 0 H; -R"COOH; -R 1 2 COOR₁ 3; -R 1 4 0R;-R' 6 COH; -R 1 7 COR 8; -R 1 9 NH₃+; -R 20 N H 2; -R 21 NR 22; -R 23 NR 24 R 2 5 +;-R 26 X or-R 27 COX, where X is any halogen atom; -R 28 SH or any combination thereof, and R 9 through R 28 comprise any linear or branched C i-C₁₂ alkyl, C i-C₁₂ alkenyl, C i -C₁₂ alkynyl, or any combination thereof, or can be absent such that the remaining portion of the functional group is covalently bound directly to one or more carbon atoms of the base aromatic ring structure. Withdrawn
The medical device of claim 1, comprising a plurality of graphene varactors configured in an array on the medical device. Original
The medical device of claim 1, wherein the self-assembled monolayer provides a Langmuir theta value of at least 0.98. Original
The medical device of claim 1, wherein the self-assembled monolayer provides coverage over the outer surface of the g raphene la y er from 50 % to 150 % by surface area. Currently amended
The medical device of claim 1, wherein the self-assembled monolayer provides coverage over the outer surface of the g raphene la y er from 99 % to 120 % by surface area. Currently amended
The medical device of claim I, the self-assembled monolayer comprising one or more of perbenzylated a -cyclodextrin, perbenzylated (3 -cyclodextrin, or perbenzylated 7 -cyclodextrin, or derivatives thereof. Withdrawn
Canceled
Canceled
A method of modifying a surface of graphene to create a graphene varactor, the method comprising: forming a self-assembled monolayer on an outer surface of a graphene layer of the graphene varactor through 7L-7L stacking interactions; quantifying the extent of surface coverage of the self-assembled monolayer using contact angle goniometry, Raman spectroscopy, or X-Ray photoelectron spectroscopy; selecting derivatized graphene layers that exhibit a Langmuir theta value of at least 0.9. Withdrawn
The method of claim 15, wherein selecting derivatized graphene layers includes selecting derivatized graphene layers that exhibit a Langmuir theta value of at least 0.98. Withdrawn
The method of claim 15, wherein the self-assembled monolayer comprises at least one selected from the group consisting of polycyclic aromatic hydrocarbons comprising 3 to aromatic rings; tetraphenylporphyrins or derivatives thereof, metallotetraphenylporphyrins or derivatives thereo f; and aromatic cyclodextrins. Withdrawn
A method for detecting an analyte comprising: collecting a gaseous sample from a patient; contacting the gaseous sample with one or more graphene varactors, each of the one or more graphene varactors comprising: a graphene layer; a self-assembled monolayer disposed on an outer surface of the graphene layer through 7E-7E stacking interactions; and wherein the self-assembled monolayer provides a Langmuir theta value of at least 0.9. Withdrawn
The method of claim 18, further comprising measuring a differential response in a capacitance of the one or more graphene varactors due to the binding of one or more analytes present in the gaseous sample. Withdrawn
The method of claim 18, wherein the self-assembled monolayer comprises at least one selected from the group consisting of polycyclic aromatic hydrocarbons comprising 3 to aromatic rings; tetraphenylporphyrins or derivatives thereof; metallotetraphenylporphyrins or derivatives thereof; and aromatic cyclodextrins. Withdrawn
Layer stacks claimed or described, ordered top of device to substrate.
graphene varactor
graphene varactor array
No layer stack recorded.
Materials described outside the worked examples.
graphene
metallotetraphenylporphyrin
Measurements and analyses referenced in the patent, with their drawing references.
FIG. 1. A gate electrode can be formed by etching a depression into the insulator layer and then depositing an electrically conductive material in the …
Performance values and ranges asserted in the specification or claims.
| Property | Value | Material |
|---|---|---|
Thickness | 1–2 mM | — |
Thickness |
Related documents with shared materials, methods, properties, or citations.
METHOD OF PREPARING GRAPHENE QUANTUM DOT, HARDMASK COMPOSITION INCLUDING THE GRAPHENE QUANTUM DOT OBTAINED BY THE METHOD, METHOD OF FORMING PATTERNS USING THE HARDMASK COMPOSITION, AND HARDMASK FORMED FROM THE HARDMASK COMPOSITION
FUNCTIONALIZED REDUCED GRAPHENE OXIDE AND METHODS OF PRODUCING THE SAME
Patent
Atlas literature
Patent
US 11,079,371Patent drawings and their descriptions. Click a drawing to enlarge it.
FIG. 1. A gate electrode can be formed by etching a depression into the insulator layer and then depositing an electrically conductive material in the …
FIG. 2. Graphene varactor 100 includes eight gate electrode fingers 106a-106h. It will be appreciated that while graphene varactor 100 shows eight gate …
FIG. 3, a schematic top plan view of a chemical sensor element 300 is shown in accordance with various embodiments herein. The chemical sensor element 300 can …
FIG. 4, a schematic diagram of a portion of a measurement zone 400 is shown in accordance with various embodiments herein. A plurality of discrete graphene …
FIG. 5, a schematic diagram of a passive sensor circuit 502 and a portion of a reading circuit 522 is shown in accordance with various aspects herein. In some …
FIG. 6, a schematic view of a system 600 for sensing gaseous analytes in accordance with various embodiments herein is shown. The system 600 can include a …
FIG. 7, a schematic view of a system 700 for sensing gaseous analytes in accordance with various embodiments herein is shown. In this embodiment, the system is …
FIG. 8, a schematic cross-sectional view is shown of a portion of a chemical sensor element 800 in accordance with various embodiments herein. The chemical …
FIG. 9. The relative surface coverage for the adsorption of Pyr-CH₂OH to graphene as a function of the logarithm of the concentration of Pyr-CH 2 OH in the …
FIG. 10. In the above example, the Langmuir model is used to determine K from contact angle data. Instead of contact angle data, the intensity of bands in …
FIG. 11) reveals five types of carbon atoms, which can be assigned to C = C (284.5 eV), C-OH (285.4 eV), C- O -C (286.4 eV), C= O (287.4 eV) and O-C= 0 (288.9 …
FIG. 12 is a representative high-resolution XPS spectrum and fits in accordance with various embodiments herein.
FIG. 13 is a representative high-resolution XPS spectrum and fits in accordance with various embodiments herein.
FIG. 14 is a representative high-resolution XPS spectrum and fits in accordance with various embodiments herein.
FIG. 15. The data show the relative monolayer coverage (dots) along with a fit (solid line) based on Langmuir adsorption theory for the adsorption of graphene …
FIG. 16. Aspects may be better understood with reference to the following examples. These examples are intended to be representative of specific embodiments, …
FIG. 17. Example 5: Synthesis of Pyr-CH 2 N(CH 2 CH 3) 2 SVG 16280635.02-20-2019.JSDP₅₇E₅RXEAPX5.SPEC.35.3.950.584.1600.894.svg 1.033 2.167 Chemistry Black and …
FIG. 18. Example 6: Synthesis of Perbenzylated a -, 3 -, and 7 -cyclodextrins SVG 16280635.02-20-2019.JSDP₅₇E₅RXEAPX5.SPEC.36.3.996.676.1554.966.svg 0.967 1.86 …
FIG. 19. The yellow liquid raw product was washed with hexane to remove most of the remaining benzyl chloride, followed by purification chromatography on …
FIG. 20. The logarithm of the concentration as a function of relative surface coverage for the adsorption of pyrene to graphene is shown in
FIG. 21. Individual data points (dots) and a fit (solid line) based on Langmuir adsorption theory for Pyr-CH 2 OH is shown in
FIG. 22. The relative surface coverage for the adsorption of Pyr-CH 2 COO CH 3 to graphene as a function of the logarithm of the concentration of Pyr-CH 2 COO …
FIG. 23. Individual data points (dots) and a fit (solid line) based on Langmuir adsorption theory for Pyr-CH 2 NH 2 HCl is shown in
FIG. 24. The relative surface coverage for the adsorption of Pyr-CH 2 NH 2 -HCl to graphene as a function of the logarithm of the concentration of Pyr-CH 2 NH …
FIG. 25. Individual data points (dots) and a fit (solid line) based on Langmuir adsorption theory for Pyr-CH 2 NH 2 is shown in
FIG. 26. The relative surface coverage for the adsorption of Pyr-CH₂NH₂ to graphene as a function of the logarithm of the concentration of Pyr- CH 2 NH 2 in …
FIG. 27.Table 2. Contact angle of DI water on bare graphene and graphene modified with Pyr- CH₂NH 2-HCl, Pyr-CH₂NH2, or Pyr-CH₂ COO CH 3. SVG …
FIG. 28. The peak height ratios for the B-OH peak (1283 SVG 16280635.02-20-2019.JSDP₅₇E₅RXEAPX5.SPEC.48.11.1512.1190.1623.1243.svg 0.177 0.37 Chemistry Black …
Claims define the patent's legal scope. Independent claims stand alone; dependent claims (nested) narrow them. Click a claim to expand its dependents.
A medical device comprising: a graphene varactor comprising: a graphene layer; a self-assembled monolayer disposed on an outer surface of the graphene layer through 7L-7L stacking interactions; and wherein the self-assembled monolayer provides a Langmuir theta value of at least 0.9i wherein the self-assembled monolayer comprises at least one metallotetraphen y lporph y rin compound having the formula SVG 16280635.03-17-2021.KMDW₆CN₆LDFLYX7.CLM.1.svg 2.95 3.86 Black and white wherein M is any metal atom comprising aluminum, calcium, magnesium, manganese, iron, cobalt, nickel, zin c, ruthenium, palladium, or derivatives thereof, where n can be any integer from 1 to 5; m can be 1 or 2; R' through R 8 comprise -H, -X, where X is any halogen atom; -R 9; -R 1 0 0H -R"COOH -R₁ 2 COOR 3; -R₁ 4 0R 15, -R₁ 6 COH-SVG 16280635.03-17-2021.KMDW₆CN₆LDFLYX7.CLM.2.svg 0.17 5.93 Black and white is any halogen atom, -R 28 SH or any combination thereof, and R 9, through R 28 comprise any linear or branched C 1-C₁₂ alkyl, C 1-C₁₂ alken y l, C 1-C₁₂ alk yny l, or any combination thereof, or can be absent such that the remaining portion of the functional group is covalently bound directly to one or more carbon atoms of the base aromatic ring structure. Currently amended
The medical device of claim 1, the self-assembled monolayer comprising one or more hydrocarbons comprising 3 to 10 aromatic rings. Withdrawn
The medical device of claim 1, the self-assembled monolayer comprising one or more polycyclic aromatic hydrocarbons comprising 3 to 10 aromatic rings. Withdrawn
The medical device of claim 1, the self-assembled monolayer comprising: SVG 16280635.03-17-2021.KMDW₆CN₆LDFLYX7.CLM.3.svg 1.28 2.89 Black and white wherein X 1, X 2, X 3, and X 4 comprise any linear, branched, or cyclic C 1-Ci o alkyl covalently bound directly to the base aromatic ring structure, -H, -R ' OH, -R 2 COO H,-SVG 16280635.03-17-2021.KMDW₆CN₆LDFLYX7.CLM.4.svg 0.18 5.87 Black and white thereof, and R 1 through R 1 2 comprise any linear, branched, or cyclic C 1-Ci o alkyl, or a combination thereof, or can be absent such that the remaining portion of the functional group is covalently bound directly to one or more carbon atoms of the base aromatic ring structure. Withdrawn
The medical device of claim 1, the self-assembled monolayer comprising: SVG 16280635.03-17-2021.KMDW₆CN₆LDFLYX7.CLM.5.svg 0.94 1.85 Black and white where n is an integer from 6 to 8, and each X can independently be -H, hydroxyl, amino, any linear or branched C 1 -C l o alcohol, any linear or branched C i -Cio amines, phenyl, benzyl, or naphthyl groups, provided that each repeating unit in the structure above includes at least one X that is an aromatic functional group. Withdrawn
The medical device of claim 1, the self-assembled monolayer comprising: SVG 16280635.03-17-2021.KMDW₆CN₆LDFLYX7.CLM.6.svg 2.83 4.02 Black and white wherein n is any integer from 1 to 5; m is 1 or 2; R 1 through R 8 comprise -H; -X, where X comprises a halogen atom; -R 9; -R 1 0 0 H; -R"COOH; -R 1 2 COOR₁ 3; -R 1 4 0R;-R' 6 COH; -R 1 7 COR 8; -R 1 9 NH₃+; -R 20 N H 2; -R 21 NR 22; -R 23 NR 24 R 2 5 +;-R 26 X or-R 27 COX, where X is any halogen atom; -R 28 SH or any combination thereof, and R 9 through R 28 comprise any linear or branched C i-C₁₂ alkyl, C i-C₁₂ alkenyl, C i -C₁₂ alkynyl, or any combination thereof, or can be absent such that the remaining portion of the functional group is covalently bound directly to one or more carbon atoms of the base aromatic ring structure. Withdrawn
The medical device of claim 1, comprising a plurality of graphene varactors configured in an array on the medical device. Original
The medical device of claim 1, wherein the self-assembled monolayer provides a Langmuir theta value of at least 0.98. Original
The medical device of claim 1, wherein the self-assembled monolayer provides coverage over the outer surface of the g raphene la y er from 50 % to 150 % by surface area. Currently amended
The medical device of claim 1, wherein the self-assembled monolayer provides coverage over the outer surface of the g raphene la y er from 99 % to 120 % by surface area. Currently amended
The medical device of claim I, the self-assembled monolayer comprising one or more of perbenzylated a -cyclodextrin, perbenzylated (3 -cyclodextrin, or perbenzylated 7 -cyclodextrin, or derivatives thereof. Withdrawn
Canceled
Canceled
A method of modifying a surface of graphene to create a graphene varactor, the method comprising: forming a self-assembled monolayer on an outer surface of a graphene layer of the graphene varactor through 7L-7L stacking interactions; quantifying the extent of surface coverage of the self-assembled monolayer using contact angle goniometry, Raman spectroscopy, or X-Ray photoelectron spectroscopy; selecting derivatized graphene layers that exhibit a Langmuir theta value of at least 0.9. Withdrawn
The method of claim 15, wherein selecting derivatized graphene layers includes selecting derivatized graphene layers that exhibit a Langmuir theta value of at least 0.98. Withdrawn
The method of claim 15, wherein the self-assembled monolayer comprises at least one selected from the group consisting of polycyclic aromatic hydrocarbons comprising 3 to aromatic rings; tetraphenylporphyrins or derivatives thereof, metallotetraphenylporphyrins or derivatives thereo f; and aromatic cyclodextrins. Withdrawn
A method for detecting an analyte comprising: collecting a gaseous sample from a patient; contacting the gaseous sample with one or more graphene varactors, each of the one or more graphene varactors comprising: a graphene layer; a self-assembled monolayer disposed on an outer surface of the graphene layer through 7E-7E stacking interactions; and wherein the self-assembled monolayer provides a Langmuir theta value of at least 0.9. Withdrawn
The method of claim 18, further comprising measuring a differential response in a capacitance of the one or more graphene varactors due to the binding of one or more analytes present in the gaseous sample. Withdrawn
The method of claim 18, wherein the self-assembled monolayer comprises at least one selected from the group consisting of polycyclic aromatic hydrocarbons comprising 3 to aromatic rings; tetraphenylporphyrins or derivatives thereof; metallotetraphenylporphyrins or derivatives thereof; and aromatic cyclodextrins. Withdrawn
Layer stacks claimed or described, ordered top of device to substrate.
graphene varactor
graphene varactor array
No layer stack recorded.
Materials described outside the worked examples.
graphene
metallotetraphenylporphyrin
Measurements and analyses referenced in the patent, with their drawing references.
FIG. 1. A gate electrode can be formed by etching a depression into the insulator layer and then depositing an electrically conductive material in the …
Performance values and ranges asserted in the specification or claims.
| Property | Value | Material |
|---|---|---|
Thickness | 1–2 mM | — |
Thickness |
Related documents with shared materials, methods, properties, or citations.
METHOD OF PREPARING GRAPHENE QUANTUM DOT, HARDMASK COMPOSITION INCLUDING THE GRAPHENE QUANTUM DOT OBTAINED BY THE METHOD, METHOD OF FORMING PATTERNS USING THE HARDMASK COMPOSITION, AND HARDMASK FORMED FROM THE HARDMASK COMPOSITION
FUNCTIONALIZED REDUCED GRAPHENE OXIDE AND METHODS OF PRODUCING THE SAME
Patent
Atlas literature
Patent
US 11,079,371Patent drawings and their descriptions. Click a drawing to enlarge it.
FIG. 1. A gate electrode can be formed by etching a depression into the insulator layer and then depositing an electrically conductive material in the …
FIG. 2. Graphene varactor 100 includes eight gate electrode fingers 106a-106h. It will be appreciated that while graphene varactor 100 shows eight gate …
FIG. 3, a schematic top plan view of a chemical sensor element 300 is shown in accordance with various embodiments herein. The chemical sensor element 300 can …
FIG. 4, a schematic diagram of a portion of a measurement zone 400 is shown in accordance with various embodiments herein. A plurality of discrete graphene …
FIG. 5, a schematic diagram of a passive sensor circuit 502 and a portion of a reading circuit 522 is shown in accordance with various aspects herein. In some …
FIG. 6, a schematic view of a system 600 for sensing gaseous analytes in accordance with various embodiments herein is shown. The system 600 can include a …
FIG. 7, a schematic view of a system 700 for sensing gaseous analytes in accordance with various embodiments herein is shown. In this embodiment, the system is …
FIG. 8, a schematic cross-sectional view is shown of a portion of a chemical sensor element 800 in accordance with various embodiments herein. The chemical …
FIG. 9. The relative surface coverage for the adsorption of Pyr-CH₂OH to graphene as a function of the logarithm of the concentration of Pyr-CH 2 OH in the …
FIG. 10. In the above example, the Langmuir model is used to determine K from contact angle data. Instead of contact angle data, the intensity of bands in …
FIG. 11) reveals five types of carbon atoms, which can be assigned to C = C (284.5 eV), C-OH (285.4 eV), C- O -C (286.4 eV), C= O (287.4 eV) and O-C= 0 (288.9 …
FIG. 12 is a representative high-resolution XPS spectrum and fits in accordance with various embodiments herein.
FIG. 13 is a representative high-resolution XPS spectrum and fits in accordance with various embodiments herein.
FIG. 14 is a representative high-resolution XPS spectrum and fits in accordance with various embodiments herein.
FIG. 15. The data show the relative monolayer coverage (dots) along with a fit (solid line) based on Langmuir adsorption theory for the adsorption of graphene …
FIG. 16. Aspects may be better understood with reference to the following examples. These examples are intended to be representative of specific embodiments, …
FIG. 17. Example 5: Synthesis of Pyr-CH 2 N(CH 2 CH 3) 2 SVG 16280635.02-20-2019.JSDP₅₇E₅RXEAPX5.SPEC.35.3.950.584.1600.894.svg 1.033 2.167 Chemistry Black and …
FIG. 18. Example 6: Synthesis of Perbenzylated a -, 3 -, and 7 -cyclodextrins SVG 16280635.02-20-2019.JSDP₅₇E₅RXEAPX5.SPEC.36.3.996.676.1554.966.svg 0.967 1.86 …
FIG. 19. The yellow liquid raw product was washed with hexane to remove most of the remaining benzyl chloride, followed by purification chromatography on …
FIG. 20. The logarithm of the concentration as a function of relative surface coverage for the adsorption of pyrene to graphene is shown in
FIG. 21. Individual data points (dots) and a fit (solid line) based on Langmuir adsorption theory for Pyr-CH 2 OH is shown in
FIG. 22. The relative surface coverage for the adsorption of Pyr-CH 2 COO CH 3 to graphene as a function of the logarithm of the concentration of Pyr-CH 2 COO …
FIG. 23. Individual data points (dots) and a fit (solid line) based on Langmuir adsorption theory for Pyr-CH 2 NH 2 HCl is shown in
FIG. 24. The relative surface coverage for the adsorption of Pyr-CH 2 NH 2 -HCl to graphene as a function of the logarithm of the concentration of Pyr-CH 2 NH …
FIG. 25. Individual data points (dots) and a fit (solid line) based on Langmuir adsorption theory for Pyr-CH 2 NH 2 is shown in
FIG. 26. The relative surface coverage for the adsorption of Pyr-CH₂NH₂ to graphene as a function of the logarithm of the concentration of Pyr- CH 2 NH 2 in …
FIG. 27.Table 2. Contact angle of DI water on bare graphene and graphene modified with Pyr- CH₂NH 2-HCl, Pyr-CH₂NH2, or Pyr-CH₂ COO CH 3. SVG …
FIG. 28. The peak height ratios for the B-OH peak (1283 SVG 16280635.02-20-2019.JSDP₅₇E₅RXEAPX5.SPEC.48.11.1512.1190.1623.1243.svg 0.177 0.37 Chemistry Black …
Claims define the patent's legal scope. Independent claims stand alone; dependent claims (nested) narrow them. Click a claim to expand its dependents.
A medical device comprising: a graphene varactor comprising: a graphene layer; a self-assembled monolayer disposed on an outer surface of the graphene layer through 7L-7L stacking interactions; and wherein the self-assembled monolayer provides a Langmuir theta value of at least 0.9i wherein the self-assembled monolayer comprises at least one metallotetraphen y lporph y rin compound having the formula SVG 16280635.03-17-2021.KMDW₆CN₆LDFLYX7.CLM.1.svg 2.95 3.86 Black and white wherein M is any metal atom comprising aluminum, calcium, magnesium, manganese, iron, cobalt, nickel, zin c, ruthenium, palladium, or derivatives thereof, where n can be any integer from 1 to 5; m can be 1 or 2; R' through R 8 comprise -H, -X, where X is any halogen atom; -R 9; -R 1 0 0H -R"COOH -R₁ 2 COOR 3; -R₁ 4 0R 15, -R₁ 6 COH-SVG 16280635.03-17-2021.KMDW₆CN₆LDFLYX7.CLM.2.svg 0.17 5.93 Black and white is any halogen atom, -R 28 SH or any combination thereof, and R 9, through R 28 comprise any linear or branched C 1-C₁₂ alkyl, C 1-C₁₂ alken y l, C 1-C₁₂ alk yny l, or any combination thereof, or can be absent such that the remaining portion of the functional group is covalently bound directly to one or more carbon atoms of the base aromatic ring structure. Currently amended
The medical device of claim 1, the self-assembled monolayer comprising one or more hydrocarbons comprising 3 to 10 aromatic rings. Withdrawn
The medical device of claim 1, the self-assembled monolayer comprising one or more polycyclic aromatic hydrocarbons comprising 3 to 10 aromatic rings. Withdrawn
The medical device of claim 1, the self-assembled monolayer comprising: SVG 16280635.03-17-2021.KMDW₆CN₆LDFLYX7.CLM.3.svg 1.28 2.89 Black and white wherein X 1, X 2, X 3, and X 4 comprise any linear, branched, or cyclic C 1-Ci o alkyl covalently bound directly to the base aromatic ring structure, -H, -R ' OH, -R 2 COO H,-SVG 16280635.03-17-2021.KMDW₆CN₆LDFLYX7.CLM.4.svg 0.18 5.87 Black and white thereof, and R 1 through R 1 2 comprise any linear, branched, or cyclic C 1-Ci o alkyl, or a combination thereof, or can be absent such that the remaining portion of the functional group is covalently bound directly to one or more carbon atoms of the base aromatic ring structure. Withdrawn
The medical device of claim 1, the self-assembled monolayer comprising: SVG 16280635.03-17-2021.KMDW₆CN₆LDFLYX7.CLM.5.svg 0.94 1.85 Black and white where n is an integer from 6 to 8, and each X can independently be -H, hydroxyl, amino, any linear or branched C 1 -C l o alcohol, any linear or branched C i -Cio amines, phenyl, benzyl, or naphthyl groups, provided that each repeating unit in the structure above includes at least one X that is an aromatic functional group. Withdrawn
The medical device of claim 1, the self-assembled monolayer comprising: SVG 16280635.03-17-2021.KMDW₆CN₆LDFLYX7.CLM.6.svg 2.83 4.02 Black and white wherein n is any integer from 1 to 5; m is 1 or 2; R 1 through R 8 comprise -H; -X, where X comprises a halogen atom; -R 9; -R 1 0 0 H; -R"COOH; -R 1 2 COOR₁ 3; -R 1 4 0R;-R' 6 COH; -R 1 7 COR 8; -R 1 9 NH₃+; -R 20 N H 2; -R 21 NR 22; -R 23 NR 24 R 2 5 +;-R 26 X or-R 27 COX, where X is any halogen atom; -R 28 SH or any combination thereof, and R 9 through R 28 comprise any linear or branched C i-C₁₂ alkyl, C i-C₁₂ alkenyl, C i -C₁₂ alkynyl, or any combination thereof, or can be absent such that the remaining portion of the functional group is covalently bound directly to one or more carbon atoms of the base aromatic ring structure. Withdrawn
The medical device of claim 1, comprising a plurality of graphene varactors configured in an array on the medical device. Original
The medical device of claim 1, wherein the self-assembled monolayer provides a Langmuir theta value of at least 0.98. Original
The medical device of claim 1, wherein the self-assembled monolayer provides coverage over the outer surface of the g raphene la y er from 50 % to 150 % by surface area. Currently amended
The medical device of claim 1, wherein the self-assembled monolayer provides coverage over the outer surface of the g raphene la y er from 99 % to 120 % by surface area. Currently amended
The medical device of claim I, the self-assembled monolayer comprising one or more of perbenzylated a -cyclodextrin, perbenzylated (3 -cyclodextrin, or perbenzylated 7 -cyclodextrin, or derivatives thereof. Withdrawn
Canceled
Canceled
A method of modifying a surface of graphene to create a graphene varactor, the method comprising: forming a self-assembled monolayer on an outer surface of a graphene layer of the graphene varactor through 7L-7L stacking interactions; quantifying the extent of surface coverage of the self-assembled monolayer using contact angle goniometry, Raman spectroscopy, or X-Ray photoelectron spectroscopy; selecting derivatized graphene layers that exhibit a Langmuir theta value of at least 0.9. Withdrawn
The method of claim 15, wherein selecting derivatized graphene layers includes selecting derivatized graphene layers that exhibit a Langmuir theta value of at least 0.98. Withdrawn
The method of claim 15, wherein the self-assembled monolayer comprises at least one selected from the group consisting of polycyclic aromatic hydrocarbons comprising 3 to aromatic rings; tetraphenylporphyrins or derivatives thereof, metallotetraphenylporphyrins or derivatives thereo f; and aromatic cyclodextrins. Withdrawn
A method for detecting an analyte comprising: collecting a gaseous sample from a patient; contacting the gaseous sample with one or more graphene varactors, each of the one or more graphene varactors comprising: a graphene layer; a self-assembled monolayer disposed on an outer surface of the graphene layer through 7E-7E stacking interactions; and wherein the self-assembled monolayer provides a Langmuir theta value of at least 0.9. Withdrawn
The method of claim 18, further comprising measuring a differential response in a capacitance of the one or more graphene varactors due to the binding of one or more analytes present in the gaseous sample. Withdrawn
The method of claim 18, wherein the self-assembled monolayer comprises at least one selected from the group consisting of polycyclic aromatic hydrocarbons comprising 3 to aromatic rings; tetraphenylporphyrins or derivatives thereof; metallotetraphenylporphyrins or derivatives thereof; and aromatic cyclodextrins. Withdrawn
Layer stacks claimed or described, ordered top of device to substrate.
graphene varactor
graphene varactor array
No layer stack recorded.
Materials described outside the worked examples.
graphene
metallotetraphenylporphyrin
Measurements and analyses referenced in the patent, with their drawing references.
FIG. 1. A gate electrode can be formed by etching a depression into the insulator layer and then depositing an electrically conductive material in the …
Performance values and ranges asserted in the specification or claims.
| Property | Value | Material |
|---|---|---|
Thickness | 1–2 mM | — |
Thickness |
Related documents with shared materials, methods, properties, or citations.
METHOD OF PREPARING GRAPHENE QUANTUM DOT, HARDMASK COMPOSITION INCLUDING THE GRAPHENE QUANTUM DOT OBTAINED BY THE METHOD, METHOD OF FORMING PATTERNS USING THE HARDMASK COMPOSITION, AND HARDMASK FORMED FROM THE HARDMASK COMPOSITION
FUNCTIONALIZED REDUCED GRAPHENE OXIDE AND METHODS OF PRODUCING THE SAME
Patent
Atlas literature
Patent
US 11,079,371Patent drawings and their descriptions. Click a drawing to enlarge it.
FIG. 1. A gate electrode can be formed by etching a depression into the insulator layer and then depositing an electrically conductive material in the …
FIG. 2. Graphene varactor 100 includes eight gate electrode fingers 106a-106h. It will be appreciated that while graphene varactor 100 shows eight gate …
FIG. 3, a schematic top plan view of a chemical sensor element 300 is shown in accordance with various embodiments herein. The chemical sensor element 300 can …
FIG. 4, a schematic diagram of a portion of a measurement zone 400 is shown in accordance with various embodiments herein. A plurality of discrete graphene …
FIG. 5, a schematic diagram of a passive sensor circuit 502 and a portion of a reading circuit 522 is shown in accordance with various aspects herein. In some …
FIG. 6, a schematic view of a system 600 for sensing gaseous analytes in accordance with various embodiments herein is shown. The system 600 can include a …
FIG. 7, a schematic view of a system 700 for sensing gaseous analytes in accordance with various embodiments herein is shown. In this embodiment, the system is …
FIG. 8, a schematic cross-sectional view is shown of a portion of a chemical sensor element 800 in accordance with various embodiments herein. The chemical …
FIG. 9. The relative surface coverage for the adsorption of Pyr-CH₂OH to graphene as a function of the logarithm of the concentration of Pyr-CH 2 OH in the …
FIG. 10. In the above example, the Langmuir model is used to determine K from contact angle data. Instead of contact angle data, the intensity of bands in …
FIG. 11) reveals five types of carbon atoms, which can be assigned to C = C (284.5 eV), C-OH (285.4 eV), C- O -C (286.4 eV), C= O (287.4 eV) and O-C= 0 (288.9 …
FIG. 12 is a representative high-resolution XPS spectrum and fits in accordance with various embodiments herein.
FIG. 13 is a representative high-resolution XPS spectrum and fits in accordance with various embodiments herein.
FIG. 14 is a representative high-resolution XPS spectrum and fits in accordance with various embodiments herein.
FIG. 15. The data show the relative monolayer coverage (dots) along with a fit (solid line) based on Langmuir adsorption theory for the adsorption of graphene …
FIG. 16. Aspects may be better understood with reference to the following examples. These examples are intended to be representative of specific embodiments, …
FIG. 17. Example 5: Synthesis of Pyr-CH 2 N(CH 2 CH 3) 2 SVG 16280635.02-20-2019.JSDP₅₇E₅RXEAPX5.SPEC.35.3.950.584.1600.894.svg 1.033 2.167 Chemistry Black and …
FIG. 18. Example 6: Synthesis of Perbenzylated a -, 3 -, and 7 -cyclodextrins SVG 16280635.02-20-2019.JSDP₅₇E₅RXEAPX5.SPEC.36.3.996.676.1554.966.svg 0.967 1.86 …
FIG. 19. The yellow liquid raw product was washed with hexane to remove most of the remaining benzyl chloride, followed by purification chromatography on …
FIG. 20. The logarithm of the concentration as a function of relative surface coverage for the adsorption of pyrene to graphene is shown in
FIG. 21. Individual data points (dots) and a fit (solid line) based on Langmuir adsorption theory for Pyr-CH 2 OH is shown in
FIG. 22. The relative surface coverage for the adsorption of Pyr-CH 2 COO CH 3 to graphene as a function of the logarithm of the concentration of Pyr-CH 2 COO …
FIG. 23. Individual data points (dots) and a fit (solid line) based on Langmuir adsorption theory for Pyr-CH 2 NH 2 HCl is shown in
FIG. 24. The relative surface coverage for the adsorption of Pyr-CH 2 NH 2 -HCl to graphene as a function of the logarithm of the concentration of Pyr-CH 2 NH …
FIG. 25. Individual data points (dots) and a fit (solid line) based on Langmuir adsorption theory for Pyr-CH 2 NH 2 is shown in
FIG. 26. The relative surface coverage for the adsorption of Pyr-CH₂NH₂ to graphene as a function of the logarithm of the concentration of Pyr- CH 2 NH 2 in …
FIG. 27.Table 2. Contact angle of DI water on bare graphene and graphene modified with Pyr- CH₂NH 2-HCl, Pyr-CH₂NH2, or Pyr-CH₂ COO CH 3. SVG …
FIG. 28. The peak height ratios for the B-OH peak (1283 SVG 16280635.02-20-2019.JSDP₅₇E₅RXEAPX5.SPEC.48.11.1512.1190.1623.1243.svg 0.177 0.37 Chemistry Black …
Claims define the patent's legal scope. Independent claims stand alone; dependent claims (nested) narrow them. Click a claim to expand its dependents.
A medical device comprising: a graphene varactor comprising: a graphene layer; a self-assembled monolayer disposed on an outer surface of the graphene layer through 7L-7L stacking interactions; and wherein the self-assembled monolayer provides a Langmuir theta value of at least 0.9i wherein the self-assembled monolayer comprises at least one metallotetraphen y lporph y rin compound having the formula SVG 16280635.03-17-2021.KMDW₆CN₆LDFLYX7.CLM.1.svg 2.95 3.86 Black and white wherein M is any metal atom comprising aluminum, calcium, magnesium, manganese, iron, cobalt, nickel, zin c, ruthenium, palladium, or derivatives thereof, where n can be any integer from 1 to 5; m can be 1 or 2; R' through R 8 comprise -H, -X, where X is any halogen atom; -R 9; -R 1 0 0H -R"COOH -R₁ 2 COOR 3; -R₁ 4 0R 15, -R₁ 6 COH-SVG 16280635.03-17-2021.KMDW₆CN₆LDFLYX7.CLM.2.svg 0.17 5.93 Black and white is any halogen atom, -R 28 SH or any combination thereof, and R 9, through R 28 comprise any linear or branched C 1-C₁₂ alkyl, C 1-C₁₂ alken y l, C 1-C₁₂ alk yny l, or any combination thereof, or can be absent such that the remaining portion of the functional group is covalently bound directly to one or more carbon atoms of the base aromatic ring structure. Currently amended
The medical device of claim 1, the self-assembled monolayer comprising one or more hydrocarbons comprising 3 to 10 aromatic rings. Withdrawn
The medical device of claim 1, the self-assembled monolayer comprising one or more polycyclic aromatic hydrocarbons comprising 3 to 10 aromatic rings. Withdrawn
The medical device of claim 1, the self-assembled monolayer comprising: SVG 16280635.03-17-2021.KMDW₆CN₆LDFLYX7.CLM.3.svg 1.28 2.89 Black and white wherein X 1, X 2, X 3, and X 4 comprise any linear, branched, or cyclic C 1-Ci o alkyl covalently bound directly to the base aromatic ring structure, -H, -R ' OH, -R 2 COO H,-SVG 16280635.03-17-2021.KMDW₆CN₆LDFLYX7.CLM.4.svg 0.18 5.87 Black and white thereof, and R 1 through R 1 2 comprise any linear, branched, or cyclic C 1-Ci o alkyl, or a combination thereof, or can be absent such that the remaining portion of the functional group is covalently bound directly to one or more carbon atoms of the base aromatic ring structure. Withdrawn
The medical device of claim 1, the self-assembled monolayer comprising: SVG 16280635.03-17-2021.KMDW₆CN₆LDFLYX7.CLM.5.svg 0.94 1.85 Black and white where n is an integer from 6 to 8, and each X can independently be -H, hydroxyl, amino, any linear or branched C 1 -C l o alcohol, any linear or branched C i -Cio amines, phenyl, benzyl, or naphthyl groups, provided that each repeating unit in the structure above includes at least one X that is an aromatic functional group. Withdrawn
The medical device of claim 1, the self-assembled monolayer comprising: SVG 16280635.03-17-2021.KMDW₆CN₆LDFLYX7.CLM.6.svg 2.83 4.02 Black and white wherein n is any integer from 1 to 5; m is 1 or 2; R 1 through R 8 comprise -H; -X, where X comprises a halogen atom; -R 9; -R 1 0 0 H; -R"COOH; -R 1 2 COOR₁ 3; -R 1 4 0R;-R' 6 COH; -R 1 7 COR 8; -R 1 9 NH₃+; -R 20 N H 2; -R 21 NR 22; -R 23 NR 24 R 2 5 +;-R 26 X or-R 27 COX, where X is any halogen atom; -R 28 SH or any combination thereof, and R 9 through R 28 comprise any linear or branched C i-C₁₂ alkyl, C i-C₁₂ alkenyl, C i -C₁₂ alkynyl, or any combination thereof, or can be absent such that the remaining portion of the functional group is covalently bound directly to one or more carbon atoms of the base aromatic ring structure. Withdrawn
The medical device of claim 1, comprising a plurality of graphene varactors configured in an array on the medical device. Original
The medical device of claim 1, wherein the self-assembled monolayer provides a Langmuir theta value of at least 0.98. Original
The medical device of claim 1, wherein the self-assembled monolayer provides coverage over the outer surface of the g raphene la y er from 50 % to 150 % by surface area. Currently amended
The medical device of claim 1, wherein the self-assembled monolayer provides coverage over the outer surface of the g raphene la y er from 99 % to 120 % by surface area. Currently amended
The medical device of claim I, the self-assembled monolayer comprising one or more of perbenzylated a -cyclodextrin, perbenzylated (3 -cyclodextrin, or perbenzylated 7 -cyclodextrin, or derivatives thereof. Withdrawn
Canceled
Canceled
A method of modifying a surface of graphene to create a graphene varactor, the method comprising: forming a self-assembled monolayer on an outer surface of a graphene layer of the graphene varactor through 7L-7L stacking interactions; quantifying the extent of surface coverage of the self-assembled monolayer using contact angle goniometry, Raman spectroscopy, or X-Ray photoelectron spectroscopy; selecting derivatized graphene layers that exhibit a Langmuir theta value of at least 0.9. Withdrawn
The method of claim 15, wherein selecting derivatized graphene layers includes selecting derivatized graphene layers that exhibit a Langmuir theta value of at least 0.98. Withdrawn
The method of claim 15, wherein the self-assembled monolayer comprises at least one selected from the group consisting of polycyclic aromatic hydrocarbons comprising 3 to aromatic rings; tetraphenylporphyrins or derivatives thereof, metallotetraphenylporphyrins or derivatives thereo f; and aromatic cyclodextrins. Withdrawn
A method for detecting an analyte comprising: collecting a gaseous sample from a patient; contacting the gaseous sample with one or more graphene varactors, each of the one or more graphene varactors comprising: a graphene layer; a self-assembled monolayer disposed on an outer surface of the graphene layer through 7E-7E stacking interactions; and wherein the self-assembled monolayer provides a Langmuir theta value of at least 0.9. Withdrawn
The method of claim 18, further comprising measuring a differential response in a capacitance of the one or more graphene varactors due to the binding of one or more analytes present in the gaseous sample. Withdrawn
The method of claim 18, wherein the self-assembled monolayer comprises at least one selected from the group consisting of polycyclic aromatic hydrocarbons comprising 3 to aromatic rings; tetraphenylporphyrins or derivatives thereof; metallotetraphenylporphyrins or derivatives thereof; and aromatic cyclodextrins. Withdrawn
Layer stacks claimed or described, ordered top of device to substrate.
graphene varactor
graphene varactor array
No layer stack recorded.
Materials described outside the worked examples.
graphene
metallotetraphenylporphyrin
Measurements and analyses referenced in the patent, with their drawing references.
FIG. 1. A gate electrode can be formed by etching a depression into the insulator layer and then depositing an electrically conductive material in the …
Performance values and ranges asserted in the specification or claims.
| Property | Value | Material |
|---|---|---|
Thickness | 1–2 mM | — |
Thickness |
Related documents with shared materials, methods, properties, or citations.
METHOD OF PREPARING GRAPHENE QUANTUM DOT, HARDMASK COMPOSITION INCLUDING THE GRAPHENE QUANTUM DOT OBTAINED BY THE METHOD, METHOD OF FORMING PATTERNS USING THE HARDMASK COMPOSITION, AND HARDMASK FORMED FROM THE HARDMASK COMPOSITION
FUNCTIONALIZED REDUCED GRAPHENE OXIDE AND METHODS OF PRODUCING THE SAME
hydrocarbons with 3 to 10 aromatic rings
polycyclic aromatic hydrocarbons
polycyclic aromatic hydrocarbons including anthracene, benzoanthracene, phenanthrene, phenalene, naphthacene, benzanthracene, chrysene, pentacene, dibenzanthracene, triphenylene, pyrene, benzopyrene, picene, perylene, benzoperylene, pentaphene, anthanthrene, coronene, ovalene
functionalized aromatic compound with substituents X₁-X₄ (tetraphenylporphyrin-type, claim 5 structure)
perbenzylated cyclodextrin (alpha, beta, or gamma)
aromatic cyclodextrins (cyclic oligosaccharide with aromatic substituents, n=6-8)
tetraphenylporphyrin
perbenzylated alpha-cyclodextrin
perbenzylated beta-cyclodextrin
perbenzylated gamma-cyclodextrin
FIG. 10. In the above example, the Langmuir model is used to determine K from contact angle data. Instead of contact angle data, the intensity of bands in …
FIG. 10. In the above example, the Langmuir model is used to determine K from contact angle data. Instead of contact angle data, the intensity of bands in …
FIG. 11) reveals five types of carbon atoms, which can be assigned to C = C (284.5 eV), C-OH (285.4 eV), C- O -C (286.4 eV), C= O (287.4 eV) and O-C= 0 (288.9 …
FIG. 12 is a representative high-resolution XPS spectrum and fits in accordance with various embodiments herein.
FIG. 13 is a representative high-resolution XPS spectrum and fits in accordance with various embodiments herein.
FIG. 14 is a representative high-resolution XPS spectrum and fits in accordance with various embodiments herein.
FIG. 15. The data show the relative monolayer coverage (dots) along with a fit (solid line) based on Langmuir adsorption theory for the adsorption of graphene …
FIG. 28. The peak height ratios for the B-OH peak (1283 SVG 16280635.02-20-2019.JSDP₅₇E₅RXEAPX5.SPEC.48.11.1512.1190.1623.1243.svg 0.177 0.37 Chemistry Black …
| 0.3–3.6 mM |
| — |
Thickness | 0.05–5 mm | — |
Thickness | 0.2–10 cm | — |
Thickness | 0.2–8 cm | — |
Thickness | 0–10 nm | — |
hydrocarbons with 3 to 10 aromatic rings
polycyclic aromatic hydrocarbons
polycyclic aromatic hydrocarbons including anthracene, benzoanthracene, phenanthrene, phenalene, naphthacene, benzanthracene, chrysene, pentacene, dibenzanthracene, triphenylene, pyrene, benzopyrene, picene, perylene, benzoperylene, pentaphene, anthanthrene, coronene, ovalene
functionalized aromatic compound with substituents X₁-X₄ (tetraphenylporphyrin-type, claim 5 structure)
perbenzylated cyclodextrin (alpha, beta, or gamma)
aromatic cyclodextrins (cyclic oligosaccharide with aromatic substituents, n=6-8)
tetraphenylporphyrin
perbenzylated alpha-cyclodextrin
perbenzylated beta-cyclodextrin
perbenzylated gamma-cyclodextrin
FIG. 10. In the above example, the Langmuir model is used to determine K from contact angle data. Instead of contact angle data, the intensity of bands in …
FIG. 10. In the above example, the Langmuir model is used to determine K from contact angle data. Instead of contact angle data, the intensity of bands in …
FIG. 11) reveals five types of carbon atoms, which can be assigned to C = C (284.5 eV), C-OH (285.4 eV), C- O -C (286.4 eV), C= O (287.4 eV) and O-C= 0 (288.9 …
FIG. 12 is a representative high-resolution XPS spectrum and fits in accordance with various embodiments herein.
FIG. 13 is a representative high-resolution XPS spectrum and fits in accordance with various embodiments herein.
FIG. 14 is a representative high-resolution XPS spectrum and fits in accordance with various embodiments herein.
FIG. 15. The data show the relative monolayer coverage (dots) along with a fit (solid line) based on Langmuir adsorption theory for the adsorption of graphene …
FIG. 28. The peak height ratios for the B-OH peak (1283 SVG 16280635.02-20-2019.JSDP₅₇E₅RXEAPX5.SPEC.48.11.1512.1190.1623.1243.svg 0.177 0.37 Chemistry Black …
| 0.3–3.6 mM |
| — |
Thickness | 0.05–5 mm | — |
Thickness | 0.2–10 cm | — |
Thickness | 0.2–8 cm | — |
Thickness | 0–10 nm | — |
hydrocarbons with 3 to 10 aromatic rings
polycyclic aromatic hydrocarbons
polycyclic aromatic hydrocarbons including anthracene, benzoanthracene, phenanthrene, phenalene, naphthacene, benzanthracene, chrysene, pentacene, dibenzanthracene, triphenylene, pyrene, benzopyrene, picene, perylene, benzoperylene, pentaphene, anthanthrene, coronene, ovalene
functionalized aromatic compound with substituents X₁-X₄ (tetraphenylporphyrin-type, claim 5 structure)
perbenzylated cyclodextrin (alpha, beta, or gamma)
aromatic cyclodextrins (cyclic oligosaccharide with aromatic substituents, n=6-8)
tetraphenylporphyrin
perbenzylated alpha-cyclodextrin
perbenzylated beta-cyclodextrin
perbenzylated gamma-cyclodextrin
FIG. 10. In the above example, the Langmuir model is used to determine K from contact angle data. Instead of contact angle data, the intensity of bands in …
FIG. 10. In the above example, the Langmuir model is used to determine K from contact angle data. Instead of contact angle data, the intensity of bands in …
FIG. 11) reveals five types of carbon atoms, which can be assigned to C = C (284.5 eV), C-OH (285.4 eV), C- O -C (286.4 eV), C= O (287.4 eV) and O-C= 0 (288.9 …
FIG. 12 is a representative high-resolution XPS spectrum and fits in accordance with various embodiments herein.
FIG. 13 is a representative high-resolution XPS spectrum and fits in accordance with various embodiments herein.
FIG. 14 is a representative high-resolution XPS spectrum and fits in accordance with various embodiments herein.
FIG. 15. The data show the relative monolayer coverage (dots) along with a fit (solid line) based on Langmuir adsorption theory for the adsorption of graphene …
FIG. 28. The peak height ratios for the B-OH peak (1283 SVG 16280635.02-20-2019.JSDP₅₇E₅RXEAPX5.SPEC.48.11.1512.1190.1623.1243.svg 0.177 0.37 Chemistry Black …
| 0.3–3.6 mM |
| — |
Thickness | 0.05–5 mm | — |
Thickness | 0.2–10 cm | — |
Thickness | 0.2–8 cm | — |
Thickness | 0–10 nm | — |
hydrocarbons with 3 to 10 aromatic rings
polycyclic aromatic hydrocarbons
polycyclic aromatic hydrocarbons including anthracene, benzoanthracene, phenanthrene, phenalene, naphthacene, benzanthracene, chrysene, pentacene, dibenzanthracene, triphenylene, pyrene, benzopyrene, picene, perylene, benzoperylene, pentaphene, anthanthrene, coronene, ovalene
functionalized aromatic compound with substituents X₁-X₄ (tetraphenylporphyrin-type, claim 5 structure)
perbenzylated cyclodextrin (alpha, beta, or gamma)
aromatic cyclodextrins (cyclic oligosaccharide with aromatic substituents, n=6-8)
tetraphenylporphyrin
perbenzylated alpha-cyclodextrin
perbenzylated beta-cyclodextrin
perbenzylated gamma-cyclodextrin
FIG. 10. In the above example, the Langmuir model is used to determine K from contact angle data. Instead of contact angle data, the intensity of bands in …
FIG. 10. In the above example, the Langmuir model is used to determine K from contact angle data. Instead of contact angle data, the intensity of bands in …
FIG. 11) reveals five types of carbon atoms, which can be assigned to C = C (284.5 eV), C-OH (285.4 eV), C- O -C (286.4 eV), C= O (287.4 eV) and O-C= 0 (288.9 …
FIG. 12 is a representative high-resolution XPS spectrum and fits in accordance with various embodiments herein.
FIG. 13 is a representative high-resolution XPS spectrum and fits in accordance with various embodiments herein.
FIG. 14 is a representative high-resolution XPS spectrum and fits in accordance with various embodiments herein.
FIG. 15. The data show the relative monolayer coverage (dots) along with a fit (solid line) based on Langmuir adsorption theory for the adsorption of graphene …
FIG. 28. The peak height ratios for the B-OH peak (1283 SVG 16280635.02-20-2019.JSDP₅₇E₅RXEAPX5.SPEC.48.11.1512.1190.1623.1243.svg 0.177 0.37 Chemistry Black …
| 0.3–3.6 mM |
| — |
Thickness | 0.05–5 mm | — |
Thickness | 0.2–10 cm | — |
Thickness | 0.2–8 cm | — |
Thickness | 0–10 nm | — |